NCT04423601View on ClinicalTrials.gov

Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

July 29, 2020

Study Completion Date

February 2, 2021

Conditions
Healthy Subjects
Interventions
DRUG

SHR6390 tablet

single oral dose of SHR6390 or co-administered with itraconazole.

DRUG

Itraconazole capsule

200 mg itraconazole was administered in the morning.

Trial Locations (1)

510120

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04423601 - Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects | Biotech Hunter | Biotech Hunter